Impact of enzalutamide, an androgen receptor (AR) signalling inhibitor, on time to first skeletal related event (SRE) and pain in the phase 3 AFFIRM study

✍ Scribed by Loriot, Y.; Fizazi, K.; Saad, F.; Sternberg, C.; Miller, K.; Mulders, P.; Chi, K.; Hirmand, M.; Selby, B.; De Bono, J.

• Book ID: 122450212
• Publisher: Association Franaise dUrologie
• Year: 2012
• Tongue: French
• Weight: 41 KB
• Volume: 22
• Category: Article
• ISSN: 1166-7087
• DOI: 10.1016/j.purol.2012.08.094